Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Onconetix is a biotech company specializing in the research, development, and commercialization of diagnostic and therapeutic solutions for men's health and oncology. Its core products include Proclarix, a blood test for prostate cancer risk assessment, and ENTADFI, an FDA-approved drug for BPH. The company leverages proprietary biomarkers, regulatory expertise, and third-party manufacturing to address cancer detection, prognosis, and treatment, serving global markets with a focus on innovation and strategic partnerships.
This description was generated via AI from an annual report. Updated about 1 year ago.